|
Market Closed -
OTC Markets
12:38:36 2026-05-04 EDT
|
5-day change | 1st Jan Change | ||
| 4.000 USD | +25.00% |
|
-.--% | +25.00% |
Company Valuation: RetinalGenix Technologies Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 155.4 | 54.35 | 94.87 | 59.54 |
| Change | - | -65.04% | 74.56% | -37.25% |
| Enterprise Value (EV) 1 | 155.6 | 54.86 | 95.39 | 60.07 |
| Change | - | -64.75% | 73.89% | -37.03% |
| P/E | -35.8x | -25.6x | -21.8x | -24.5x |
| PBR | -145x | -38.8x | -66.5x | -26.1x |
| PEG | -0x | 0.5x | -0.2x | 0.5x |
| Capitalization / Revenue | - | - | - | - |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | - | - | - | - |
| EV / EBIT | -82.9x | -26.3x | -22.1x | -24.8x |
| EV / FCF | -387x | - | - | 171x |
| FCF Yield | -0.26% | - | - | 0.58% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -0.2511 | -0.1205 | -0.2408 | -0.1308 |
| Distribution rate | - | - | - | - |
| Net sales | - | - | - | - |
| EBITDA | -1.876 | -2.087 | -4.317 | -2.425 |
| EBIT 1 | -1.876 | -2.087 | -4.317 | -2.425 |
| Net income 1 | -3.914 | -2.091 | -4.321 | -2.429 |
| Net Debt 1 | 0.1581 | 0.5065 | 0.5183 | 0.53 |
| Reference price 2 | 9.000 | 3.090 | 5.250 | 3.200 |
| Nbr of stocks (in thousands) | 17,272 | 17,589 | 18,071 | 18,605 |
| Announcement Date | 3/31/23 | 4/1/24 | 3/31/25 | 4/15/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 75.37M | |
| 34.78x | 6.2x | 18.42x | 0.92% | 51.61B | |
| -21.47x | 297.59x | -22.09x | -.--% | 44.89B | |
| 33.46x | 3.25x | 14.02x | -.--% | 42.77B | |
| 49.05x | 5.7x | 31.17x | -.--% | 42.58B | |
| 29.21x | 8.45x | 21.35x | 0.39% | 31.82B | |
| 35.3x | 5.79x | 26.33x | -.--% | 17.33B | |
| 24.28x | 2.11x | 9.13x | 1.11% | 14.76B | |
| 78.97x | 4.14x | 16.07x | -.--% | 14.09B | |
| Average | 32.95x | 41.65x | 14.30x | 0.3% | 28.88B | |
| Weighted average by Cap. | 28.33x | 55.88x | 13.02x | 0.29% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- RTGN Stock
- Valuation RetinalGenix Technologies Inc.
Select your edition
All financial news and data tailored to specific country editions
